AKT1 and nasopharyngeal carcinoma: EBV encodes latent membrane protein 1 (LMP1), which contributes to loss of function of PTEN, an inhibitor of the PI3K/Akt pathway, by upregulating miR-21, thus potentiating NPC [39] and promoting chemoresistance [40].